Literature DB >> 25081732

Antisocial and psychopathic personalities in a sample of addicted subjects: differences in psychological resources, symptoms, alexithymia and impulsivity.

Alessio Gori1, Giuseppe Craparo2, Giuseppe Iraci Sareri3, Vincenzo Caretti4, Marco Giannini1, Patrizia Meringolo1.   

Abstract

OBJECTIVE: Psychopathy and antisocial personality disorder (ASPD) are two constructs not interchangeable. Compared to the ASPD, psychopathy is characterized by lack of anxiety, low withdrawal, and high levels of attention seeking.
METHOD: The sample of this study included 76 subjects with a substance use disorder. Subjects were aged between 18 and 59 years old (M=32.87, SD=9.36). With respect to level of education 3 subjects are elementary school graduates, 49 have a middle school diploma, 21 own a high school diploma, and 3 participants have a bachelor's degree. We administered the following measures: a) Psychopathic Personality Inventory-Revised (PPI-R); b) Psychological Treatment Inventory (PTI); c) 20-Item-Toronto Alexithymia Scale (TAS-20); d) Barratt Impulsiveness Scale (BIS).
RESULTS: Most of the significant correlations between the Psychopathic Index (PPI-R total score), and the measures administered are listed below: PPI-R total score and Deviance (r=.482, p<.001), PPI-R total score and Hypomania (r=.369, p < .001), PPI-R total score and Unresolved attachment (r=.293, p<.001), PPI-R total score and Manipulativeness (r=.550, p<.001), PPI-R total score and the TAS-20 total score (r=.230; p<.001), PPI-R total score and Difficulty in Identifying Feelings (DIF) factor (r=.250, p<.001), PPI-R total score and Attentional Impulsiveness (r=.409, p<.001); PPI-R total score and Motor Impulsiveness (r=.526, p<.001). Results of MANOVAs between the two groups also revealed significant differences on several variables analyzed.
CONCLUSIONS: Our study showed that addicted subjects with psychopathic tendencies are more likely to experience negative emotions and have a peculiar cognitive style with respect to antisocial addicts. These results partially confirm those ones of previous studies underlining that psychopathic population is generally characterized for a major need for stimulation, poor behavioral controls, lack of realistic long-term goals, impulsivity, irresponsibility.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25081732     DOI: 10.1016/j.comppsych.2014.05.023

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  6 in total

1.  Associations between serotonin transporter and behavioral traits and diagnoses related to anxiety.

Authors:  Ardesheer Talati; Zagaa Odgerel; Priya J Wickramaratne; Andrea Norcini-Pala; Jamie L Skipper; Jay A Gingrich; Myrna M Weissman
Journal:  Psychiatry Res       Date:  2017-03-21       Impact factor: 3.222

2.  Relationship between Parenting and Cognitive Schemas in a Group of Male Adult Offenders.

Authors:  Monica Pellerone; Giuseppe Craparo; Ylenia Tornabuoni
Journal:  Front Psychol       Date:  2016-03-07

3.  Effect of Narcissism, Psychopathy, and Machiavellianism on Entrepreneurial Intention-The Mediating of Entrepreneurial Self-Efficacy.

Authors:  Wenqing Wu; Hongxin Wang; Chundong Zheng; Yenchun Jim Wu
Journal:  Front Psychol       Date:  2019-02-21

4.  Relationships Between Alexithymia and Psychopathy in Heroin Dependent Individuals.

Authors:  Elena Psederska; Svetoslav Savov; Nikola Atanassov; Jasmin Vassileva
Journal:  Front Psychol       Date:  2019-10-09

5.  Psychopathological Features and Drop-Out Predictors in a Sample of Individuals with Substance Use Disorder Under Residential Community Treatment.

Authors:  Alessio Gori; Eleonora Topino; Ilaria Bagnoli; Giuseppe Iraci-Sareri; Giuseppe Craparo
Journal:  Clin Neuropsychiatry       Date:  2020-02

6.  A New Measure for Assessing Substance-Related and Addictive Disorders: The Addictive Behavior Questionnaire (ABQ).

Authors:  Vincenzo Caretti; Alessio Gori; Giuseppe Craparo; Marco Giannini; Giuseppe Iraci-Sareri; Adriano Schimmenti
Journal:  J Clin Med       Date:  2018-08-01       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.